BioCardia, Inc.
(NASDAQ : BCDA)

( )
BCDA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.45%98.560.0%$1438.14m
BIIBBiogen, Inc. -0.36%242.511.7%$630.38m
AMGNAmgen, Inc. -0.79%220.461.3%$568.17m
GILDGilead Sciences, Inc. 0.60%60.251.0%$535.76m
VRTXVertex Pharmaceuticals, Inc. -0.63%216.501.9%$470.81m
REGNRegeneron Pharmaceuticals, Inc. -3.34%506.102.7%$447.76m
BNTXBioNTech SE -4.35%101.870.0%$424.45m
ILMNIllumina, Inc. 1.25%305.633.5%$377.98m
NVAXNovavax, Inc. 1.44%95.3392.9%$339.05m
EXASEXACT Sciences Corp. -2.72%117.2619.6%$289.27m
MGENMiragen Therapeutics, Inc. -4.62%16.500.7%$248.55m
SRRKScholar Rock Holding Corp. 3.14%42.700.0%$242.63m
APVOAptevo Therapeutics, Inc. -3.58%43.9218.3%$210.20m
SGENSeagen Inc. -2.05%164.635.8%$167.34m
ALXNAlexion Pharmaceuticals, Inc. 0.41%123.112.0%$161.56m

Company Profile

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.